Edward Podgorski Iii, MD
Pain Medicine · Tampa, FLNPI 1760832828
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 64.3% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $19,206, more than ten times the $345 reported in 2020. Among pain medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 365 payments — averaging $149.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$35K
- Tersera Therapeutics LLC$12K
- Abbott$3K
- Boston Scientific$962
- Relievant Medsystems, Inc.$772
- SPR Therapeutics, Inc$602
- plus $2K from 23 others
What the payments were for
- Consulting fees$10,19719%
- Speaking & faculty fees$22,55041%
- Travel & lodging$7,30313%
- Food & beverage$13,39625%
- Education$1,1072%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 198 | $35,102 |
| Tersera Therapeutics LLC | 45 | $12,168 |
| Abbott | 20 | $2,699 |
| Boston Scientific | 27 | $962 |
| Relievant Medsystems, Inc. | 8 | $772 |
| SPR Therapeutics, Inc | 11 | $602 |
| Piramal Critical Care | 1 | $600 |
| AbbVie | 16 | $359 |
| Nevro Corp. | 6 | $291 |
| Curonix LLC | 3 | $154 |
| Pacira Therapeutics, Inc. | 1 | $124 |
| Sanofi-aventis U.S. LLC | 1 | $118 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $113 |
| Scilex Pharmaceuticals Inc. | 5 | $96 |
| MML US, Inc. | 2 | $78 |
| Saluda Medical Americas, Inc. | 1 | $41 |
| Bard Peripheral Vascular, Inc. | 1 | $37 |
| Vertex | 1 | $26 |
| Lundbeck LLC | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Si-bone, Inc. | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Globus Medical | 1 | $20 |
| Stryker | 1 | $19 |
| Avanos Medical | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Merit Medical Systems Inc | 1 | $14 |
| Vertos Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$18,740
- PRIALT$11,216
- SYNCHROMEDII$8,338
- GABLOFEN$2,400
- Intracept$2,043
- KYPHON EXPRESS II KYPHOPAK TRAY$1,391
- Proclaim IPG$1,076
- KYPHON Balloon Kyphoplasty$576
- Proclaim DRG IPG$534
- INCEPTIV$299
- PROCLAIM$267
- SYNCHROMED$267
- ETERNA$178
- PROTG$171
- INTELLIS$165
- Intracept RF Probe$164
- Senza Spinal Cord Stimulation System$150
- OSTEOCOOL RF ABLATION SYSTEM$145
- Zilretta$124
- TZIELD$118
How this compares
$54,551 in reported general payments places this provider in the 95th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 84 | $46,046 |
| BelbucaBuprenorphine Hcl | 17 | $12,627 |
| Oxycodone Hcl | 433 | $11,085 |
| Fentanyl | 82 | $6,586 |
| Xtampza ErOxycodone Myristate | 12 | $6,451 |
| Morphine Sulfate ErMorphine Sulfate | 83 | $3,225 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 119 | $3,197 |
| Celecoxib | 107 | $2,578 |
| Hydromorphone Hcl | 60 | $2,062 |
| Naloxone Hcl | 34 | $2,034 |
| Duloxetine Hcl | 141 | $1,815 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 67 | $1,658 |
| Methadone Hcl | 84 | $1,526 |
| Gabapentin | 168 | $1,445 |
| Ondansetron OdtOndansetron | 59 | $1,225 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $23 | $19,07829 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate | $21 | $1,00738 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 596 pain medicine providers in Florida.
Other pain medicine in Tampa
- Rodolfo GariTampa$120K
- Arun KalavaTampa$36K
- Mauricio OrbegozoTampa$31K
- Robert GuirguisTampa$30K
- Abraham RiveraTampa$27K
- Jorge LealTampa$18K
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.